Ion Beam Applications SA (IOBCF)
USD 10.95
(-0.68%)
USD 10.95
(-0.68%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 41.58 Million EUR | 1.75% |
| 2022 | 40.86 Million EUR | -40.75% |
| 2021 | 68.97 Million EUR | -19.91% |
| 2020 | 86.12 Million EUR | 27.83% |
| 2019 | 67.37 Million EUR | -21.46% |
| 2018 | 85.78 Million EUR | 100.67% |
| 2017 | 42.75 Million EUR | 42.97% |
| 2016 | 29.9 Million EUR | -5.6% |
| 2015 | 31.67 Million EUR | -0.63% |
| 2014 | 31.87 Million EUR | -32.28% |
| 2013 | 47.07 Million EUR | -33.21% |
| 2012 | 70.47 Million EUR | 28.02% |
| 2011 | 55.05 Million EUR | 21.26% |
| 2010 | 45.4 Million EUR | 612.52% |
| 2009 | 6.37 Million EUR | -82.37% |
| 2008 | 36.13 Million EUR | 38.02% |
| 2007 | 26.18 Million EUR | 10.92% |
| 2006 | 23.6 Million EUR | -7.11% |
| 2005 | 25.41 Million EUR | 52.8% |
| 2004 | 16.63 Million EUR | -68.97% |
| 2003 | 53.6 Million EUR | -70.86% |
| 2002 | 183.96 Million EUR | -20.99% |
| 2001 | 232.83 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 32.43 Million EUR | 84.91% |
| 2024 Q1 | 32.43 Million EUR | -21.99% |
| 2023 Q3 | 35.47 Million EUR | -14.68% |
| 2023 Q2 | 41.58 Million EUR | 16.28% |
| 2023 Q1 | 35.76 Million EUR | -12.49% |
| 2023 Q4 | 41.58 Million EUR | 17.2% |
| 2023 FY | 41.58 Million EUR | 1.75% |
| 2022 Q1 | 59.04 Million EUR | -14.39% |
| 2022 Q4 | 40.86 Million EUR | 16.13% |
| 2022 FY | 40.86 Million EUR | -40.75% |
| 2022 Q3 | 35.19 Million EUR | -45.64% |
| 2022 Q2 | 64.74 Million EUR | 9.64% |
| 2021 Q4 | 68.97 Million EUR | 8.43% |
| 2021 Q3 | 63.61 Million EUR | -17.14% |
| 2021 Q1 | 71.96 Million EUR | -16.44% |
| 2021 FY | 68.97 Million EUR | -19.91% |
| 2021 Q2 | 76.77 Million EUR | 6.68% |
| 2020 Q1 | 87.5 Million EUR | 29.88% |
| 2020 Q2 | 92.15 Million EUR | 5.31% |
| 2020 Q3 | 81.32 Million EUR | -11.75% |
| 2020 Q4 | 86.12 Million EUR | 5.9% |
| 2020 FY | 86.12 Million EUR | 27.83% |
| 2019 FY | 67.37 Million EUR | -21.46% |
| 2019 Q4 | 67.37 Million EUR | 7.79% |
| 2019 Q1 | 87.54 Million EUR | 2.04% |
| 2019 Q3 | 62.5 Million EUR | -31.5% |
| 2019 Q2 | 91.24 Million EUR | 4.23% |
| 2018 Q1 | 75.38 Million EUR | 76.35% |
| 2018 FY | 85.78 Million EUR | 100.67% |
| 2018 Q4 | 85.78 Million EUR | -10.61% |
| 2018 Q3 | 95.97 Million EUR | 27.3% |
| 2018 Q2 | 75.38 Million EUR | 0.0% |
| 2017 Q3 | 42.75 Million EUR | 48.49% |
| 2017 Q2 | 28.79 Million EUR | 0.14% |
| 2017 Q1 | 28.75 Million EUR | -3.85% |
| 2017 Q4 | 42.75 Million EUR | 0.0% |
| 2017 FY | 42.75 Million EUR | 42.97% |
| 2016 Q1 | 30.81 Million EUR | -2.72% |
| 2016 Q3 | 29.75 Million EUR | -3.91% |
| 2016 FY | 29.9 Million EUR | -5.6% |
| 2016 Q2 | 30.96 Million EUR | 0.48% |
| 2016 Q4 | 29.9 Million EUR | 0.51% |
| 2015 Q1 | 29.07 Million EUR | -8.78% |
| 2015 Q4 | 31.67 Million EUR | 0.65% |
| 2015 FY | 31.67 Million EUR | -0.63% |
| 2015 Q2 | 29.27 Million EUR | 0.69% |
| 2015 Q3 | 31.47 Million EUR | 7.48% |
| 2014 Q2 | 34.47 Million EUR | 0.0% |
| 2014 Q3 | 31.67 Million EUR | -8.1% |
| 2014 Q4 | 31.87 Million EUR | 0.62% |
| 2014 Q1 | 34.47 Million EUR | -26.77% |
| 2014 FY | 31.87 Million EUR | -32.28% |
| 2013 FY | 47.07 Million EUR | -33.21% |
| 2013 Q4 | 47.07 Million EUR | 0.43% |
| 2013 Q3 | 46.87 Million EUR | -41.14% |
| 2013 Q2 | 79.62 Million EUR | 0.0% |
| 2013 Q1 | 79.62 Million EUR | 12.98% |
| 2012 FY | 70.47 Million EUR | 28.02% |
| 2012 Q4 | 70.47 Million EUR | 0.0% |
| 2012 Q3 | - EUR | -100.0% |
| 2012 Q2 | 74.57 Million EUR | 0.0% |
| 2011 Q2 | 43.01 Million EUR | 0.0% |
| 2011 FY | 55.05 Million EUR | 21.26% |
| 2011 Q4 | 55.05 Million EUR | 0.0% |
| 2010 FY | 45.4 Million EUR | 612.52% |
| 2010 Q4 | 45.4 Million EUR | 0.0% |
| 2010 Q2 | 72.23 Million EUR | 0.0% |
| 2009 Q4 | 6.37 Million EUR | 0.0% |
| 2009 FY | 6.37 Million EUR | -82.37% |
| 2008 FY | 36.13 Million EUR | 38.02% |
| 2007 FY | 26.18 Million EUR | 10.92% |
| 2006 FY | 23.6 Million EUR | -7.11% |
| 2005 FY | 25.41 Million EUR | 52.8% |
| 2004 FY | 16.63 Million EUR | -68.97% |
| 2003 FY | 53.6 Million EUR | -70.86% |
| 2002 FY | 183.96 Million EUR | -20.99% |
| 2001 FY | 232.83 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| IR-Med Inc. | 161 Thousand USD | -25727.95% |
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 14.83 Million USD | -180.374% |
| Medical Supply International USA, Inc. | 227 Thousand USD | -18218.341% |
| Polarean Imaging plc | 216.38 Thousand USD | -19117.136% |
| Avitar, Inc. | 5.26 Million USD | -689.767% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -9151.295% |
| Manhattan Scientifics, Inc. | 60 Thousand USD | -69205.0% |
| Össur hf. | 467.73 Million USD | 91.11% |
| Zecotek Photonics Inc. | 3.22 Million USD | -1190.653% |
| QHSLab, Inc. | 1.78 Million USD | -2234.088% |
| Wellstar International, Inc. | 51.36 Million USD | 19.047% |
| Össur hf. | 467.73 Million USD | 91.11% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | -696.91% |
| Escalon Medical Corp. | 524.71 Thousand USD | -7824.813% |
| Aurora Spine Corporation | 2.67 Million USD | -1457.089% |
| BrainsWay Ltd. | 471 Thousand USD | -8728.662% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 3 Million USD | -1286.1% |
| Hamilton Thorne Ltd. | 27.81 Million USD | -49.521% |
| Vivos Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 1.69 Billion USD | 97.551% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | -8276.931% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | -23246.284% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | -6106.418% |
| Nanomix Corporation | 11.4 Million USD | -264.563% |
| Theraclion SA | 1.95 Million EUR | -2031.657% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 4.04 Million USD | -928.777% |
| Positron Corporation | 1.78 Million USD | -2226.279% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.69 Million USD | -2348.153% |
| Lombard Medical, Inc. | 32.29 Million USD | -28.772% |
| ALR Technologies Inc. | 19.26 Million USD | -115.857% |
| Stratec SE | 156.16 Million USD | 73.372% |
| Vycor Medical, Inc. | 1.11 Million USD | -3645.379% |
| Heart Tronics, Inc. | 209.28 Thousand USD | -19769.078% |
| Nu-Med Plus, Inc. | 100 Thousand USD | -41483.0% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | -21457.436% |
| SANUWAVE Health, Inc. | 31.94 Million USD | -30.175% |
| VMS Rehab Systems, Inc. | 133.52 USD | -31143548.892% |
| Guided Therapeutics, Inc. | 2.05 Million USD | -1920.555% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | -6488.377% |
| Odyssey Group International, Inc. | 2.14 Million USD | -1838.909% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 3.17 Million USD | -1211.247% |
| Capital Group Holdings, Inc. | 4944.00 USD | -840980.097% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | -5100.092% |
| Urologix, Inc. | 5.33 Million USD | -679.73% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | -985.526% |
| Nexeon MedSystems Inc. | 4.21 Million USD | -886.499% |
| SS Innovations International, Inc. | 8.21 Million USD | -405.978% |
| Qualis Innovations, Inc. | 9102.00 USD | -456755.636% |
| Smith & Nephew plc | 3.07 Billion USD | 98.65% |
| NIOX Group Plc | 1.4 Million USD | -2869.578% |
| Fuse Medical, Inc. | 1.99 Million USD | -1985.76% |
| Broncus Holding Corporation | 2.35 Million USD | -1666.212% |
| Brain Scientific Inc. | 2.86 Million USD | -1352.182% |
| Pressure BioSciences, Inc. | 22.75 Million USD | -82.715% |
| Health Logic Interactive Inc. | 40.44 Thousand USD | -102721.324% |